Epistatically Interacting Substitutions Are Enriched during Adaptive Protein Evolution

PLoS Genetics

Volumn 10, Issue 5, 2014, Pages

  Gong, Lizhi Ian ^a   Bloom, Jesse D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; NUCLEOPROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPISTASIS; EPITOPE MAPPING; INFLUENZA; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; SEQUENCE HOMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; VIROLOGY;

EPISTASIS, GENETIC; EPITOPES; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NUCLEOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 84901627198     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004328     Document Type: Article

References (69)

1. Chou HH, Chiu HC, Delaney NF, Segre D, Marx CJ, (2011) Diminishing Returns Epistasis Among Beneficial Mutations Decelerates Adaptation. Science 332: 1190-1192.
2. Blount ZD, Borland CZ, Lenski RE, (2008) Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proc Natl Acad Sci U S A 105: 7899-7906.
3. Khan AI, Dinh DM, Schneider D, Lenski RE, Cooper TF, (2011) Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population. Science 332: 1193-1196.
4. Schenk MF, Szendro IG, Salverda ML, Krug J, de Visser JA, (2013) Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene. Mol Biol Evol 30: 1779-1787.
5. Weinreich DM, Delaney NF, Depristo MA, Hartl DL, (2006) Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312: 111-114.
6. Beadle BM, Shoichet BK, (2002) Structural bases of stability-function tradeoffs in enzymes. J Mol Biol 321: 285-296.
7. Bershtein S, Segal M, Bekerman R, Tokuriki N, Tawfik DS, (2006) Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444: 929-932.
8. Ortlund EA, Bridgham JT, Redinbo MR, Thornton JW, (2007) Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317: 1544-1548.
9. Bridgham JT, Ortlund EA, Thornton JW, (2009) An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature 461: 515-519.
10. Bloom JD, Labthavikul ST, Otey CR, Arnold FH, (2006) Protein stability promotes evolvability. Proc Natl Acad Sci U S A 103: 5869-5874.
11. Barton NH, (2000) Genetic hitchhiking. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences 355: 1553-1562.
12. Chen RB, Holmes EC, (2010) Hitchhiking and the Population Genetic Structure of Avian Influenza Virus. Journal of molecular evolution 70: 98-105.
13. Kimura M (1983) The Neutral Theory of Molecular Evolution. Cambridge, U.K.: Cambridge University Press.
14. King JL, Jukes TH, (1969) Non-Darwinian evolution. Science 164: 788-798.
15. Lang GI, Rice DP, Hickman MJ, Sodergren E, Weinstock GM, et al. (2013) Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500: 571-574.
16. Lynch M, (2007) The frailty of adaptive hypotheses for the origins of organismal complexity. Proc Natl Acad Sci U S A 104 Suppl 1: 8597-8604.
17. Nei M, (2005) Selectionism and neutralism in molecular evolution. Mol Biol Evol 22: 2318-2342.
18. Sideraki V, Huang W, Palzkill T, Gilbert HF, (2001) A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci U S A 98: 283-288.
19. Wang X, Minasov G, Shoichet BK, (2002) Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol 320: 85-95.
20. Covert AW 3rd, Lenski RE, Wilke CO, Ofria C, (2013) Experiments on the role of deleterious mutations as stepping stones in adaptive evolution. Proc Natl Acad Sci U S A 110: E3171-3178.
21. Draghi JA, Parsons TL, Plotkin JB, (2011) Epistasis increases the rate of conditionally neutral substitution in an adapting population. Genetics 187: 1139-1152.
22. Draghi JA, Plotkin JB, (2013) Selection biases the prevalence and type of epistasis along adaptive trajectories. Evolution; international journal of organic evolution 67: 3120-3131.
23. Szendro IG, Schenk MF, Franke J, Krug J, de Visser JAGM, (2013) Quantitative analyses of empirical fitness landscapes. J Stat Mech 2013: P01005 doi:10.1088/1742-5468/2013/01/P01005.
24. Portela A, Digard P, (2002) The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol 83: 723-734.
25. Ye Q, Krug RM, Tao YJ, (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444: 1078-1082.
26. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
27. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619.
28. Gerhard W, Yewdell J, Frankel ME, Webster R, (1981) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713-717.
29. Wiley DC, Wilson IA, Skehel JJ, (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
30. Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, et al. (2004) Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 103: 97-100.
31. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, et al. (2004) A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol 78: 5216-5222.
32. Berkhoff EG, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF, (2007) Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones. J Gen Virol 88: 530-535.
33. Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, et al. (2011) Immunity to seasonal and pandemic influenza A viruses. Microbes and infection/Institut Pasteur 13: 489-501.
34. Gong LI, Suchard MA, Bloom JD, (2013) Stability-mediated epistasis constrains the evolution of an influenza protein. eLife 2: e00631.
35. Renard C, Hart E, Sehra H, Beasley H, Coggill P, et al. (2006) The genomic sequence and analysis of the swine major histocompatibility complex. Genomics 88: 96-+.
36. Adams EJ, Parham P, (2001) Species-specific evolution of MHC class I genes in the higher primates. Immunological Reviews 183: 41-64.
37. Sheerar MG, Easterday BC, Hinshaw VS, (1989) Antigenic conservation of H1N1 swine influenza viruses. J Gen Virol 70 (Pt 12) (): 3297-3303.
38. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA, (2008) Swine influenza viruses a North American perspective. Advances in virus research 72: 127-154.
39. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Gramer MR, et al. (2006) Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Veterinary microbiology 118: 212-222.
40. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
41. Luoh SM, McGregor MW, Hinshaw VS, (1992) Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J Virol 66: 1066-1073.
42. Noble S, McGregor MS, Wentworth DE, Hinshaw VS, (1993) Antigenic and genetic conservation of the haemagglutinin in H1N1 swine influenza viruses. J Gen Virol 74 (Pt 6) (): 1197-1200.
43. Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB, et al. (2010) Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2: 24ra21.
44. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, et al. (2013) Integrating influenza antigenic dynamics with molecular evolution. Elife 3: e01914 doi:10.7554/eLife.01914.
45. dos Reis M, Hay AJ, Goldstein RA, (2009) Using non-homogeneous models of nucleotide substitution to identify host shift events: application to the origin of the 1918 'Spanish' influenza pandemic virus. Journal of molecular evolution 69: 333-345.
46. Morens DM, Taubenberger JK, Fauci AS, (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361: 225-229.
47. Brockwell-Staats C, Webster RG, Webby RJ, (2009) Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza and other respiratory viruses 3: 207-213.
48. Taubenberger JK, Kash JC, (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell host & microbe 7: 440-451.
49. Minin VN, Suchard MA, (2008) Counting labeled transitions in continuous-time Markov models of evolution. Journal of mathematical biology 56: 391-412.
50. O'Brien JD, Minin VN, Suchard MA, (2009) Learning to count: robust estimates for labeled distances between molecular sequences. Mol Biol Evol 26: 801-814.
51. Drummond AJ, Suchard MA, Xie D, Rambaut A, (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969-1973.
52. Bhatt S, Holmes EC, Pybus OG, (2011) The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol 28: 2443-2451.
53. DiBrino M, Parker KC, Margulies DH, Shiloach J, Turner RV, et al. (1995) Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry 34: 10130-10138.
54. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, et al. (2000) Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74: 6800-6807.
55. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, et al. (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82: 12241-12251.
56. Alexander J, Bilsel P, del Guercio MF, Marinkovic-Petrovic A, Southwood S, et al. (2010) Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. Human immunology 71: 468-474.
57. Cheung YK, Cheng SC, Ke Y, Xie Y, (2012) Human immunogenic T cell epitopes in nucleoprotein of human influenza A (H5N1) virus. Hong Kong medical journal 18 Suppl 2: 17-21.
58. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, et al. (2010) The immune epitope database 2.0. Nucleic Acids Res 38: D854-862.
59. Sidney J, Peters B, Frahm N, Brander C, Sette A, (2008) HLA class I supertypes: a revised and updated classification. BMC immunology 9: 1.
60. da Silva J, Hughes AL, (1998) Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 15: 1259-1268.
61. Hertz T, Nolan D, James I, John M, Gaudieri S, et al. (2011) Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 85: 1310-1321.
62. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
63. Krasnitz M, Levine AJ, Rabadan R, (2008) Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 82: 8947-8950.
64. Stamatakis A, (2006) RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22: 2688-2690.
65. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC evolutionary biology 7: 214.
66. Jones DT, Taylor WR, Thornton JM, (1992) The rapid generation of mutation data matrices from protein sequences. Computer applications in the biosciences: CABIOS 8: 275-282.
67. Bloom JD, Gong LI, Baltimore D, (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275.
68. Bloom JD, Nayak JS, Baltimore D, (2011) A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS ONE 6: e22201.
69. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108-6113.